<DOC>
	<DOCNO>NCT03025009</DOCNO>
	<brief_summary>The main purpose study investigate side effect related LY3192767 give injection skin healthy participant . Blood test do check much LY3192767 absorb bloodstream , long take body get rid , affect blood sugar level . The study two part : Part A Part B . Each participant enroll one part . For participant , Part A last 32 day last dose Part B last 49 day last dose . Screening must complete prior study start .</brief_summary>
	<brief_title>A Study LY3192767 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Are overtly healthy male female , determine medical history physical examination Have body mass index ( BMI ) &gt; 18.5 &lt; 30.0 kilogram per square meter ( kg/mÂ² ) , inclusive Are currently enrol clinical trial involve investigational product type medical research judge scientifically medically compatible study Have participate , within last 30 day , clinical trial involve investigational product . If previous investigational product long halflife , 3 month 5 halflives ( whichever longer ) pass Have participate participant firstinhuman study within 90 day initial dose study drug Have know allergy insulin , heparin , related drug , history relevant allergic reaction origin Have history presence cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , hematological , chronic inflammatory disease , neurological disorder capable significantly alter absorption , metabolism , elimination drug ; constitute risk take study medication ; interfere interpretation data</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>